Class settlements are designed for the average class member, and Fortune 500 companies are not average. Shinder Cantor Lerner’s Kellie Lerner examines the structural reasons large corporate buyers routinely recover less than their potential damages in antitrust class actions.
General counsels at Fortune 100 companies are paid to protect value. You negotiate contracts, manage risk and advise the board on decisions worth billions. So let me ask you something direct: When your company receives a class-action notice, what happens next?
If the answer is, “We file a claim and wait,” you may be systematically undervaluing one of your most significant legal assets quarter after quarter without ever realizing the cost. Antitrust class actions are not a back-office compliance exercise. For large corporate purchasers, they represent a genuine revenue-generation opportunity.
The question is whether your legal department is positioned to capture it. Here are three reasons you should take a hard look at your current approach.
A staggering gap
Class settlements are designed for the average class member. Fortune 500 companies are not average.
See Settlement in Vitamin Case is Approved, N.Y. TIMEs, Mar. 31, 2000, at C5. See also In re Vitamins Antitrust litigation, No. 99-197 (TFH), 2000 U.S. Dist. LEXIS 8931, at *35 (S.D.N.Y. Mar. 30, 2000) (approving settlement agreement).
In In re Vitamins Antitrust Litigation, opt-out plaintiffs recovered $2 billion while the entire class settled for approximately $300 million. The University of California, as an opt-out plaintiff in In re AOL Time Warner, Inc. Securities & “ERISA” Litigation, recovered between 16 and 24 times more than it would have received had it remained a class member. In In re Linerboard Antitrust Litigation, each opt-out received $1.9 million from a single defendant while class members received $1,772. And in In re Methionine Antitrust Litigation, opt-out Quaker Oats recovered three times what class members received.
These are not outliers. They are the expected outcome when a sophisticated company with significant affected purchases decides to pursue its claims directly rather than accept whatever the class negotiated on its behalf.
The reason is structural. Class damages models are built on industry averages. They are designed to efficiently compensate thousands of class members across a wide range of purchase volumes and market positions. If your company was a major buyer in an affected market, those averages often understate your actual harm. When you stay in the class, you accept a pro-rata share of a settlement pool calibrated to the class as a whole, not to your company’s specific circumstances. Opt-out plaintiffs, by contrast, can build individualized damages models that reflect their actual purchasing data, business relationships and economic exposure. That difference in methodology translates directly into dollars recovered.
The gap between knowing and doing is striking. In a 2022 survey of 150 US general counsels and senior in-house litigation leaders, 60% reported that their companies mostly or always remain in the class, while 8% mostly or always opt out. The consequences are measurable: 56% of companies that stayed in their respective classes routinely recovered less than 25% of their potential monetary damages. Yet the barriers keeping companies in the class are largely structural, not strategic.
Nearly two-thirds of those surveyed reported that the cost of opting out exceeds the available budget, not that opting out was the wrong legal call. Companies that typically opt out are also more than three times as likely to hold claims worth over $50 million than those that remain in the class. Among GCs whose companies do opt out, the two most compelling drivers are greater control over counsel, litigation strategy and settlement (54%) and the expectation of significantly higher monetary recovery than the class would yield (52%).
In other words, the companies capturing the most value aren’t just chasing dollars; they’re treating litigation as a managed business function.
Canaries in the Coal Mine: Law’s Crashout Over AI Is Coming for Everyone
Shadow AI & lack of proper guardrails are problematic combination
Read moreDetailsTiming is a trap
The opt-out decision is not something you revisit when the clock is already running. Courts are unforgiving, and the procedural requirements are strictly enforced.
Consider what happened to two potential opt outs in the In re Turkey Antitrust Litigation. There, two companies missed an opt-out deadline by a single day, attributing the error to honest internal mistakes. The court was unmoved and denied a request to opt out. This is a recurring story, and it happens to sophisticated companies with capable legal teams who simply did not have the right system in place.
One more assumption worth dispelling: Don’t expect a second opt-out opportunity at settlement. Neither due process nor Rule 23 requires it, and courts rarely exercise their discretion to provide one. If you miss your window at class certification, you are in the class. Period.
The practical default recommendation is to wait until class certification before opting out to benefit from class counsel’s investigative work and your limitations period often stays protected. But that only works if your monitoring infrastructure is already in place before the certification order lands.
Many companies lack effective internal processes, but they’re not complex
This is the blunt reality for many legal departments. Class-action notices arrive, get routed somewhere and often don’t receive the rigorous financial analysis they warrant. The right people aren’t always in the room. Deadlines aren’t always communicated with the urgency they deserve. And critically, no one has analyzed the value of an individual opt-out recovery relative to the company’s pro-rata class share.
Companies that consistently capture opt-out value operate differently. They have built a deliberate system: centralized identification of relevant antitrust lawsuit notices routed directly to the legal department; a dedicated reviewer responsible for tracking the opt-out triggering events; automated deadline calendaring so that opt-out windows never quietly close; and a financial analysis protocol that calculates affected purchase volume, estimates individualized damages and compares that figure against the company’s projected pro-rata class share.
These companies also apply a clear threshold test: the stronger the underlying case — particularly where there are DOJ guilty pleas or FTC findings that de-risk the liability question — and the larger the company’s financial stake relative to the class, the stronger the case for opting out. Business relationship considerations, resource appetite for litigation and jurisdictional factors are also part of the calculus. But none of that analysis can happen if the notice of the class action has already been forwarded to accounts payable and the deadline has passed.
Opting out is not the right move in every case. It requires resources, carries litigation risk and demands clear-eyed assessment across multiple dimensions. But for large corporate buyers in significant antitrust matters, staying in the class by default — without ever seriously evaluating the alternative — is a passive decision with an active cost.
Kellie Lerner is the founding and managing partner of Shinder Cantor Lerner, a boutique antitrust litigation firm with offices in New York and Washington, D.C. 
